meglumine has been researched along with gamma-linolenic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryce, R; Etienne, MC; Ferrero, JM; Fischel, JL; Formento, P; Ilc, K; Milano, G | 1 |
| Birch, BR; Cooper, AJ; Crook, TJ; Dyer, JP; McCormick, RI | 1 |
| Bass, P; Birch, BR; Cooper, AJ; Crook, TJ; Dyer, JP; Harris, NM; Solomon, LZ | 1 |
| Anderson, WR; Birch, BR; Cooper, AJ; Harris, NM; Lwaleed, BA; Solomon, LZ | 1 |
| Agombar, A; Cooper, AJ; Johnson, CD | 1 |
1 trial(s) available for meglumine and gamma-linolenic acid
| Article | Year |
|---|---|
Intravesical meglumine gamma-linolenic acid in superficial bladder cancer: an efficacy study.
Topics: Administration, Intravesical; Adult; Carcinoma, Transitional Cell; Drug Combinations; Female; gamma-Linolenic Acid; Humans; Male; Meglumine; Treatment Outcome; Urinary Bladder Neoplasms | 2002 |
4 other study(ies) available for meglumine and gamma-linolenic acid
| Article | Year |
|---|---|
Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study on human glioblastoma cell lines.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Survival; Drug Interactions; Drug Screening Assays, Antitumor; gamma-Linolenic Acid; Glioblastoma; Humans; Lithium Compounds; Meglumine; Nitrosourea Compounds; Organophosphorus Compounds; Tumor Cells, Cultured | 1999 |
The effects of meglumine gamma linolenic acid (MeGLA) on an organ culture model of superficial bladder cancer.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; gamma-Linolenic Acid; Humans; Meglumine; Neoplasms, Experimental; Organ Culture Techniques; Rats; Rats, Wistar; Urinary Bladder Neoplasms | 2002 |
Epirubicin and meglumine gamma-linolenic acid: a logical choice of combination therapy for patients with superficial bladder carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Division; Drug Synergism; Epirubicin; Flow Cytometry; gamma-Linolenic Acid; Humans; Meglumine; Microscopy, Confocal; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |
An aqueous formulation of gamma-linolenic acid with anti-proliferative action on human pancreatic cancer cell lines.
Topics: Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; gamma-Linolenic Acid; Humans; Lithium Compounds; Meglumine; Pancreatic Neoplasms; Solutions; Time Factors; Tumor Cells, Cultured; Water | 2004 |